← Back to Search

Atopic Dermatitis Adherence Study

N/A
Waitlist Available
Led By James H Bergman, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the use of moisturizer among both groups could be used as an indirect measure of adherence to treatment
Awards & highlights
No Placebo-Only Group

Summary

Forgetting is usually listed as the most important cause of low adherence among patients. Most studies to date have looked at the adherence of adults or adolescent population. No studies have been done looking specifically at adherence to topical treatment by parents/caregivers of young children. Our project will try to replicate the same results among the parents/caregivers responsible for children ten years and under. The population in this study will be the parents/caregivers of children 10 and under with atopic dermatitis and the intervention will be the effect of electronic reminders in adherence rates for the use of a moisturizer which is recognized as part of the standard of care in the treatment of atopic dermatitis.

Eligible Conditions
  • Eczema

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~effects of electronic reminders on the adherence of 20 parents/caregivers at the end of 28 days study
This trial's timeline: 3 weeks for screening, Varies for treatment, and effects of electronic reminders on the adherence of 20 parents/caregivers at the end of 28 days study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Secondary study objectives
EASI score changes
Moisturizer

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: electronic remindersExperimental Treatment1 Intervention
In this group, the parents/caregivers will receive two daily electronic reminders in addition to the standard of care.
Group II: control groupActive Control1 Intervention
Parents/caregivers will receive the standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
electronic reminders
2012
N/A
~74770

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,481 Previous Clinical Trials
2,494,876 Total Patients Enrolled
1 Trials studying Eczema
120 Patients Enrolled for Eczema
James H Bergman, MDPrincipal InvestigatorUniversity of British Columbia
~4 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top